Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in medullary thyroid carcinoma patients
Titel:
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in medullary thyroid carcinoma patients
Auteur:
Maina, Theodosia Konijnenberg, Mark W. KolencPeitl, Petra Garnuszek, Piotr Nock, Berthold A. Kaloudi, Aikaterini Kroselj, Marko Zaletel, Katja Maecke, Helmut Mansi, Rosalba Erba, Paola von Guggenberg, Elisabeth Hubalewska-Dydejczyk, Alicja Mikolajczak, Renata Decristoforo, Clemens